Skip to main content
. 2022 Nov 8;29(11):8501–8512. doi: 10.3390/curroncol29110670

Table 1.

Comparison of the study cohort background characteristics before pretransplant therapy.

Variables VTD (n = 62) VCD (n = 43) p-Value *
Age 0.935
18–64 years 10 (16.1%) 6 (14.0%)
65–75 years 25 (40.3%) 17 (39.5%)
>75 years 27 (43.5%) 20 (46.5%)
Sex 0.816
Men 39 (62.9%) 28 (65.1%)
Women 23 (37.1%) 15 (34.9%)
BMI 0.107
Underweight (<18.5 kg/m2) 8 (12.9%) 6 (14.0%)
Normal weight (18.5–25.0 kg/m2) 32 (51.6%) 20 (46.5%)
Overweight (>25.0 kg/m2) 22 (35.5%) 17 (39.5%)
Area of residence (urban) 34 (54.8%) 26 (60.5%) 0.566
Relationship status (married) 57 (91.9%) 40 (93.0%) 0.836
Occupation (retired) 52 (83.9%) 37 (86.0%) 0.760
Substance use behavior
Frequent alcohol consumption 11 (17.7%) 9 (20.9%) 0.682
Frequent smoker 20 (32.3%) 16 (37.2%) 0.599
Chronic comorbidities **
High blood pressure 38 (61.3%) 24 (55.8%) 0.574
Lung 10 (16.1%) 6 (14.0%) 0.760
Metabolic 13 (21.0%) 9 (20.9%) 0.996
Cerebrovascular 16 (25.8%) 15 (34.9%) 0.315
Digestive & liver 6 (9.7%) 4 (9.3%) 0.948
Depression 7 (11.3%) 4 (9.3%) 0.743
Other 5 (8.1%) 3 (7.0%) 0.836

* Chi-squared or Fisher’s exact test. ** Excluding severe pulmonary restriction or obstruction, evidence of heart failure, kidney failure, and other types of malignancies. BMI—body mass index.